214 related articles for article (PubMed ID: 27995049)
1. Annexin A3 Knockdown Suppresses Lung Adenocarcinoma.
Liu YF; Liu QQ; Zhang YH; Qiu JH
Anal Cell Pathol (Amst); 2016; 2016():4131403. PubMed ID: 27995049
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.
Du R; Liu B; Zhou L; Wang D; He X; Xu X; Zhang L; Niu C; Liu S
Cell Death Dis; 2018 Jan; 9(2):126. PubMed ID: 29374148
[TBL] [Abstract][Full Text] [Related]
3. Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway.
Xu R; Yin J; Zhang Y; Zhang S
J Cell Biochem; 2019 Sep; 120(9):14585-14593. PubMed ID: 30998268
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells.
Wang L; Li X; Ren Y; Geng H; Zhang Q; Cao L; Meng Z; Wu X; Xu M; Xu K
Cancer Sci; 2019 May; 110(5):1609-1620. PubMed ID: 30868675
[TBL] [Abstract][Full Text] [Related]
5. 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis
Guo C; Li N; Dong C; Wang L; Li Z; Liu Q; Ma Q; Greenaway FT; Tian Y; Hao L; Liu S; Sun MZ
J Adv Res; 2021 May; 30():85-102. PubMed ID: 34026289
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
Kim JY; Jung EJ; Park HJ; Lee JH; Song EJ; Kwag SJ; Park JH; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC
Clin Breast Cancer; 2018 Aug; 18(4):e713-e719. PubMed ID: 29217453
[TBL] [Abstract][Full Text] [Related]
8. GBX2, as a tumor promoter in lung adenocarcinoma, enhances cells viability, invasion and migration by regulating the AKT/ERK signaling pathway.
Wang Y; Hui J; Li R; Fu Q; Yang P; Xiao Y; Hui J
J Gene Med; 2020 Feb; 22(2):e3147. PubMed ID: 31758726
[TBL] [Abstract][Full Text] [Related]
9. Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.
Wei S; Zhang ZY; Fu SL; Xie JG; Liu XS; Xu YJ; Zhao JP; Xiong WN
Cell Death Dis; 2016 Sep; 7(9):e2388. PubMed ID: 27685632
[TBL] [Abstract][Full Text] [Related]
10. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
11. Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma.
Pan QZ; Pan K; Weng DS; Zhao JJ; Zhang XF; Wang DD; Lv L; Jiang SS; Zheng HX; Xia JC
Mol Carcinog; 2015 Aug; 54(8):598-607. PubMed ID: 24375474
[TBL] [Abstract][Full Text] [Related]
12. MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin.
Mo D; Yang D; Xiao X; Sun R; Huang L; Xu J
Biotechnol Lett; 2017 May; 39(5):701-710. PubMed ID: 28120164
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of KCNJ4 correlates with cancer progression and unfavorable prognosis in lung adenocarcinoma.
Wu XY; Yu XY
J Biochem Mol Toxicol; 2019 Apr; 33(4):e22270. PubMed ID: 30512237
[TBL] [Abstract][Full Text] [Related]
14. ANXA3 deletion inhibits the resistance of lung cancer cells to oxaliplatin.
Jin YF; Huang YT; Chen PF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3741-3748. PubMed ID: 32329851
[TBL] [Abstract][Full Text] [Related]
15. Microglial Annexin A3 promoted the development of melanoma via activation of hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway.
Xu B; Zhang X; Gao Y; Song J; Shi B
J Clin Lab Anal; 2021 Feb; 35(2):e23622. PubMed ID: 33118214
[TBL] [Abstract][Full Text] [Related]
16. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
[TBL] [Abstract][Full Text] [Related]
17. Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells.
Wu KC; Yang ST; Hsia TC; Yang JS; Chiou SM; Lu CC; Wu RS; Chung JG
Anticancer Res; 2012 Nov; 32(11):4833-42. PubMed ID: 23155249
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ANXA3 is an independent prognostic indicator in gastric cancer and its depletion suppresses cell proliferation and tumor growth.
Wang K; Li J
Oncotarget; 2016 Dec; 7(52):86972-86984. PubMed ID: 27894078
[TBL] [Abstract][Full Text] [Related]
19. Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling.
Kake S; Usui T; Ohama T; Yamawaki H; Sato K
Oncol Rep; 2017 Feb; 37(2):1100-1106. PubMed ID: 28075459
[TBL] [Abstract][Full Text] [Related]
20. Silencing of Livin inhibits tumorigenesis and metastasis via VEGF and MMPs pathway in lung cancer.
Lin X; Li HR; Lin XF; Yu ME; Tu XW; Hua ZD; Lin M; Xu NL; Han LL; Chen YS
Int J Oncol; 2015 Aug; 47(2):657-67. PubMed ID: 26094984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]